Literature DB >> 32540279

Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease.

David de la Rosa Carrillo1, José Luís López-Campos2, Bernardino Alcázar Navarrete3, Myriam Calle Rubio4, Rafael Cantón Moreno5, Juan Luis García-Rivero6, Luís Máiz Carro7, Casilda Olveira Fuster8, Miguel Ángel Martínez-García9.   

Abstract

Although the chronic presence of microorganisms in the airways of patients with stable chronic obstructive pulmonary disease (COPD) confers a poor outcome, no recommendations have been established in disease management guidelines on how to diagnose and treat these cases. In order to guide professionals, the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) has prepared a document which aims to answer questions on the clinical management of COPD patients in whom microorganisms are occasionally or habitually isolated. Since the available scientific evidence is too heterogeneous to use in the creation of a clinical practice guideline, we have drawn up a document based on existing scientific literature and clinical experience, addressing the definition of different clinical situations and their diagnosis and management. The text was drawn up by consensus and approved by a large group of respiratory medicine experts with extensive clinical and scientific experience in the field, and has been endorsed by the SEPAR Scientific Committee.
Copyright © 2020 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bronchiectasis; Bronquiectasias; Chronic bronchial infection; Chronic obstructive pulmonary disease; Corticosteroides inhalados; Enfermedad pulmonar obstructiva crónica; Infección bronquial crónica; Inhaled antibiotic treatment; Inhaled corticosteroids; Macrolides; Macrólidos; Tratamiento antibiótico inhalado

Mesh:

Year:  2020        PMID: 32540279     DOI: 10.1016/j.arbres.2020.04.023

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  14 in total

1.  Traction bronchiectasis: is it as benign as we think?

Authors:  Amina Bekki; Thais Beauperthuy; Miguel Ángel Martínez-García
Journal:  J Bras Pneumol       Date:  2022-07-25       Impact factor: 2.800

2.  Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes.

Authors:  Xuejie Wang; Casilda Olveira; Rosa Girón; Marta García-Clemente; Luis Máiz; Oriol Sibila; Rafael Golpe; Rosario Menéndez; Juan Rodríguez-López; Concepción Prados; Miguel Angel Martinez-García; Juan Luis Rodriguez; David de la Rosa; Liyun Qin; Xavier Duran; Jordi Garcia-Ojalvo; Esther Barreiro
Journal:  Biomedicines       Date:  2022-04-30

Review 3.  Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.

Authors:  Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive
Journal:  Arch Bronconeumol       Date:  2022-04-15       Impact factor: 6.333

4.  A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.

Authors:  Luis Pérez de Llano; Marc Miravitlles; Rafael Golpe; Francisco Javier Alvarez-Gutiérrez; Carolina Cisneros; Carlos Almonacid; Eva Martinez-Moragon; Francisco-Javier Gonzalez-Barcala; David Ramos-Barbón; Vicente Plaza; Jose Luis Lopez-Campos; Juan Pablo de-Torres; Ciro Casanova; Juan Luis Garcia Rivero; Juan Rodriguez Hermosa; Myriam Calle Rubio; Juan Jose Soler-Cataluña; Borja G Cosio
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-04

Review 5.  [Current microbiological aspects of community respiratory infection beyond COVID-19].

Authors:  R Cantón
Journal:  Rev Esp Quimioter       Date:  2021-03-22       Impact factor: 1.553

6.  Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD.

Authors:  Hanaa Shafiek; Javier Verdú; Amanda Iglesias; Lluisa Ramon-Clar; Nuria Toledo-Pons; Carla Lopez-Causape; Carlos Juan; Pablo Fraile-Ribot; Antonio Oliver; Borja G Cosio
Journal:  BMJ Open Respir Res       Date:  2021-10

7.  ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group.

Authors:  Letizia Traversi; Marc Miravitlles; Miguel Angel Martinez-Garcia; Michal Shteinberg; Apostolos Bossios; Katerina Dimakou; Joseph Jacob; John R Hurst; Pier Luigi Paggiaro; Sebastian Ferri; Georgios Hillas; Jens Vogel-Claussen; Sabine Dettmer; Stefano Aliberti; James D Chalmers; Eva Polverino
Journal:  ERJ Open Res       Date:  2021-11-22

8.  Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis.

Authors:  Miguel Angel Martinez-García; David Rigau; Miriam Barrecheguren; Alberto García-Ortega; Alexa Nuñez; Grace Oscullo Yepez; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-02-16

Review 9.  The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management.

Authors:  Miguel Angel Martinez-Garcia; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-03-23

10.  Variability of blood eosinophil count and prognosis of COPD exacerbations.

Authors:  Sandra Martínez-Gestoso; María-Teresa García-Sanz; Uxío Calvo-Álvarez; Liliana Doval-Oubiña; Sandra Camba-Matos; Francisco-Javier Salgado; Xavier Muñoz; Purificación Perez-Lopez-Corona; Francisco-Javier González-Barcala
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.